Patents Assigned to Lyfjathroun hf.
  • Patent number: 6855332
    Abstract: The present invention relates to pharmaceutical compositions comprising polyoxyethylene glycol, fatty acid mono- and diglyceride ester as an absorption promoting agent and an absorption controlling agent together with a therapeutically, prophylactically and/or diagnostically active substance. The pharmaceutical compositions are especially suitable for mucosal administration such as intranasal administration.
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: February 15, 2005
    Assignee: Lyfjathroun hf.
    Inventors: Sveinbjorn Gizurarson, Sigridur Olafsdottir, Jakob Lindal Kristinsson, Kolbrun Hrafnkelsdottir, David Rurik Olafsson, Oddur Ingolfsson, Ellen Ruth Ingimundardottir
  • Publication number: 20040005275
    Abstract: The present invention relates to pharmaceutical compositions comprising polyoxyethylene glycol, fatty acid mono- and diglyceride ester as an absorption promoting agent and an absorption controlling agent together with a therapeutically, prophylactically and/or diagnostically active substance. The pharmaceutical compositions are especially suitable for mucosal administration such as intranasal administration.
    Type: Application
    Filed: July 29, 2002
    Publication date: January 8, 2004
    Applicant: Lyfjathroun hf.
    Inventors: Sveinbjorn Gizurarson, Sigridur Olafsdottir, Jakob Lindal Kristinsson, Kolbrun Hrafnkelsdottir, David Rurik Olafsson, Oddur Ingolfsson, Ellen Ruth Ingimundardottir